Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 916-236-0 | (10E,14E,16E,22Z)-(1R,4S,5'S,6S,6'R,8R,12S,13S,20R,21R,24S)-6'-[(S)-sec-butyl]-21,24-dihydroxy-5',11,13,22-tetramethyl-2-oxo-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6-spiro-2'-(5',6'-dihydro-2'H-pyran)-12-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-3-O-methyl-α-L-arabino-hexopyranoside |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 2 | H300 | H300 | EUH401 |
GHS09 GHS06 Dgr |
State/Form
|
3 | View details | ||||
| Acute Tox. 2 | H330 | H330 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| STOT RE 1 | H372 (neuro) (oral) | H372 | |||||||||
| STOT RE 1 | H372 (other:neuro) (oral) | H372 | |||||||||
| Aquatic Acute 1 | H400 | ||||||||||
| Aquatic Chronic 1 | H410 | H410 | |||||||||
| H300 |
Wng |
State/Form
|
1 | View details | |||||||
| H330 | |||||||||||
| H361 | |||||||||||
| H372 | |||||||||||
| H400 | |||||||||||
| H300 |
GHS09 GHS06 Dgr |
State/Form
|
1 | View details | |||||||
| H332 | |||||||||||
| H400 | |||||||||||
Number of Aggregated Notifications: 3